ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 252917-06-9
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Signaling Pathways
  6. CHIR-99021; CT99021

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttp://www.medchemexpress.com/
Wechat
Product NameCHIR-99021
SynonymsCT99021
CT-99021
CHIR99021
CHIR-99021
CHIR 99021
GSK-3 Inhibitor XVI
CT 99021(CHIR 99021)

Synonyms

CT99021
CT-99021
CHIR99021
CHIR-99021
CHIR 99021
GSK-3 Inhibitor XVI
CT 99021(CHIR 99021)
6-{2-[4-(2,4-Dichloro-phenyl)-5-(4-methyl-1H-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile
6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile
3-Pyridinecarbonitrile, 6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]
CAS252917-06-9
EINECS809-015-4
Chemical FormulaC22H18Cl2N8
Molecular Weight465.34
inchi
Package10 mM * 1 mL;1 mg;5 mg;10 mg;25 mg;50 mg
PriceEmail to quote
DescriptionsLaduviglusib

Laduviglusib

MedChemExpress (MCE)

HY-10182

252917-06-9

CHIR-99021

Descriptions

Laduviglusib

Laduviglusib

MedChemExpress (MCE)

HY-10182

252917-06-9

CHIR-99021
CT99021

99.43%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 1 year -20°C 6 months

Room temperature in continental US
may vary elsewhere.

Laduviglusib (CHIR-99021) is a potent, selective and orally active GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal. Laduviglusib induces autophagy.

Laduviglusib (1-10 μM, 3 days) reduces the viability of the ES-D3 cells with an IC50 of 4.9 μM[2]. Laduviglusib (5 μM, 48 h) activates the canonical Wnt-pathway in ES-D3 cells and ES-CCE cells[2]. Laduviglusib (3 μM, 4 days) inhibits ES cell differentiation into neural cells[3]. Laduviglusib (1 μM, 2 weeks) inhibits adipogenesis by blocking induction of C/EBPα and PPARγ in 3T3-L1 preadipocytes[4]. Laduviglusib (2.5 μM, 24 h) protects Lgr5+ cells against radiation-induced apoptosis[5].

Laduviglusib (30 mg/kg, p.o) rapidly lowers plasma glucose[1]. Laduviglusib (2 mg/kg, i.p.) protects mice against radiation-induced lethal GI injury[5].

GSK-3β 6.7 nM (IC50) GSK-3α 10 nM (IC50) cdc2 8800 nM (IC50)

| | | |

| | | | | |



[1]. Ring DB, et al. Selective glycogen synthase kinase 3 inhibitors potentiate activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003 Mar
52(3):588-95.
[Content Brief]

[2]. Naujok O, et al. Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors.BMC Res Notes. 2014 Apr 29
7:273.
[Content Brief]

[3]. Ye S, et al. Pleiotropy of glycogen synthase kinase-3 inhibition by CHIR99021 promotes self-renewal of embryonic stem cells from refractory mouse strains. PLoS One. 2012
7(4):e35892.
[Content Brief]

[4]. Bennett CN, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem. 2002 Aug 23
277(34):30998-1004.
[Content Brief]

[5]. Wang X, et al. Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiation. Sci Rep. 2015 Apr 10
5:8566.
[Content Brief]

Supplier Websitehttp://www.medchemexpress.com/laduviglusib.html
Last Update2025-10-14 16:03:33
MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-10-14 16:03:33

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-10-14 16:03:33

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-10-14 16:03:33

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-10-14 16:03:33

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-10-14 16:03:33

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-10-14 16:03:33

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-10-14 16:03:33

Thalidomide-PEG4-NH2

Category: Signaling Pathways
CAS: 2387510-82-7
Last Update: 2025-10-14 16:03:33
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002